The deal sees UK-based Tate & Lyle take complete control of the oat producing Biovelop business including its production facility in Kimstad, Sweden.
Swedish firm Biovelop produces soluble fibre in the form beta-glucan under the brand name PromOat - where it is used in the food, beverage and supplement markets, due to its widely approved health claims, including EFSA approval for lowering cholesterol and reducing post prandial glycaemic response.
Olivier Rigaud, president of speciality food ingredients for Tate & Lyle said the addition of Biovelop’s soluble oat beta-glucan, supported by strong scientific health claims, represents an excellent addition to Tate & Lyle’s existing fibres and health and wellness portfolios.
Tate & Lyle will also take control of the firms production of oat beta-glucan for the cosmetics industry under the brand name Avenacare, in addition to a range of other oat-based ingredients including oat protein, oat dextrin and insoluble oat fibre.